New Rapid mood Screener Screens for Manic Symptoms and Bipolar I Disorder Features to Address Unmet Clinical Need Psychedelics Investing
COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy Psychedelics Investing
MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics Psychedelics Investing
Seelos Therapeutics to Participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference February 3-4 Psychedelics Investing
Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange Psychedelics Investing
Numinus Wellness Closes Q1 2021 with Strong Cash Position and Industry Firsts Cannabis Investing News
Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares Psychedelics Investing
COMPASS Pathways plc to participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference Psychedelics Investing
